In recent years, additional questions on indoor residual spraying, as well as biomarker testing for anemia and malaria, have been added. Other indicators include type and timing of antimalarial drugs.
MIS was developed by MERG of Roll Back Malaria and technical assistance in MIS implementation is provided by The DHS Program and other organizations.
To help countries and organizations conduct a MIS, RBM has developed a MIS Toolkit.
The standard Maternal and Child Health SPA includes a summary of the availability of malaria-related services, including availability of antimalarial medicines, treatment guidelines and protocols, and laboratory diagnostic capacity (and provider training in malaria); an assessment of malaria treatment service for sick children, prevention services among pregnant women, and malaria treatment services for HIV-positive persons; and sometimes data on distribution of insecticide-treated nets.